1) liver/toxicity
肝/毒性
2) Liver toxicity
肝脏毒性
1.
Comparative effects of chelating agents on liver toxicity in mice induced by acute exposure to cadmium;
几种螯合剂对镉致小鼠肝脏毒性解毒作用比较
2.
The Express and Principle Study of Liver Toxicity of Dioscorea bulbifera L;
黄药子对小鼠肝脏毒性的表达及其机理研究
3) Hepatotoxicity
[英][,hepətəutɔksi'siti] [美][,hɛpətotɑk'sɪsɪti, hɪ,pæto-]
肝毒性
1.
Comparison of the Stability and Hepatotoxicity of Gatifloxacin Salts with 8 Different Acids for Injection;
加替沙星的八种盐注射剂稳定性及其肝毒性比较
2.
Experimental Study on Hepatotoxicity of Fufang Qingzhi Granules in Rats;
复方清脂颗粒对大鼠的肝毒性实验研究
3.
Test on hepatotoxicity of acetaminophen using gel entrapment culture of rat hepatocytes;
凝胶包埋大鼠肝细胞用于醋氨酚肝毒性研究
4) Liver toxicity
肝毒性
1.
Experimental research on triptolide solid lipid nanoparticle for decreasing liver toxicity of triptolide;
固体脂质纳米粒降低雷公藤内酯醇肝毒性的实验研究
2.
Protective effects of Siwuheji on cisplatin induced liver toxicity in mice;
四物合剂对顺铂肝毒性作用的实验研究
5) hepatic lipotoxicity
肝脂毒性
1.
Objective To study the effects of Qushi Huayu Decoction (QHD)contained serum on fatty de- position and tumor necrosis factorα(TNF-α)secretion of hepatic lipotoxicity model in vitro,for further investi- gating the mechanism of the decoction for preventing and treating fatty liver.
目的研究祛湿化瘀方对体外肝脂毒性模型脂肪沉积和肿瘤坏死因子α(tumor necrosis factorα,TNF-α)分泌的影响,以进一步探究该方防治脂肪肝的作用机理方法复制游离脂肪酸(free fatty acid,FFA)诱导的HepG2细胞脂肪变性和TNF-α分泌脂毒性模型。
2.
Objective: To study the efficiency and effect mechanism of Herba Artemisiae Scoporiae inhibits the hepatic lipotoxicity model in vitro.
目的:研究茵陈醇提物对游离脂肪酸刺激HepG2细胞所致肝脂毒性的抑制作用及机制。
6) Hepatotoxicity
[英][,hepətəutɔksi'siti] [美][,hɛpətotɑk'sɪsɪti, hɪ,pæto-]
肝脏毒性
1.
Empirical Study on the Hepatotoxicity Induced by Rifamycin Sodium Plus Isoniazid in Mice;
利福霉素钠与异烟肼合用对小鼠肝脏毒性的实验研究
2.
Hepatotoxicity of Flos Farfarae and the Contained Alkaloid to Mice;
款冬花及其所含生物碱对小鼠肝脏毒性作用的研究
补充资料：肝脏毒性
肝脏毒性
多数药物在肝脏中进行代谢，对肝脏会造成一定损害。抗肿瘤药物对肝脏的损害主要表现在两个方面：①中毒性肝炎或胆汁瘀积。引起这种改变的药物有甲氨蝶呤、苯丁酸氮介、6-巯基嘌呤、5-氟尿嘧啶、阿糖胞苷等，主要表现为血清谷丙转氨酶的升高，重者伴有黄疸和腹水。一般停药后能自行恢复。常用的保肝药有维生素C、肝泰乐、五味子蜜丸、联苯双酯等。②肝纤维化和肝硬化。可见于长期应用甲氨蝶呤者。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条